Viking Therapeutics, Inc. (VKTX)

NASDAQ: VKTX · IEX Real-Time Price · USD

50.90

+0.80 (1.60%)

At close: Jul 19, 2024, 4:00 PM

50.86

-0.04 (-0.08%)

Pre-market: Jul 22, 2024, 7:26 AM EDT

Viking Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2013
Selling, General & Admin	37.46	37.02	16.12	10.7	10.73	9.13	Upgrade
Research & Development	76.9	63.81	54.23	44.98	31.93	23.56	Upgrade
Operating Expenses	114.36	100.83	70.36	55.68	42.66	32.69	Upgrade
Operating Income	-114.36	-100.83	-70.36	-55.68	-42.66	-32.69	Upgrade
Other Expense / Income	-20.64	-14.93	-1.49	-0.69	-3.17	-6.91	Upgrade
Pretax Income	-93.72	-85.9	-68.87	-54.99	-39.5	-25.78	Upgrade
Net Income	-93.72	-85.9	-68.87	-54.99	-39.5	-25.78	Upgrade
Shares Outstanding (Basic)	103	94	77	77	73	72	Upgrade
Shares Outstanding (Diluted)	103	94	77	77	73	72	Upgrade
Shares Change	32.04%	22.79%	-0.47%	6.34%	0.89%	24.97%	Upgrade
EPS (Basic)	-0.93	-0.91	-0.90	-0.71	-0.54	-0.36	Upgrade
EPS (Diluted)	-0.93	-0.91	-0.90	-0.71	-0.54	-0.36	Upgrade
Free Cash Flow	-54.87	-73.38	-48.4	-47.59	-21.78	-24.75	Upgrade
Free Cash Flow Per Share	-0.53	-0.78	-0.63	-0.62	-0.30	-0.34	Upgrade
EBITDA	-93.43	-85.6	-68.58	-54.69	-39.22	-25.52	Upgrade
Depreciation & Amortization	0.29	0.29	0.29	0.3	0.28	0.26	Upgrade
EBIT	-93.72	-85.9	-68.87	-54.99	-39.5	-25.78	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).